Human brain in tissue culture. IV. Morphological characteristics.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 168236)

Published in J Comp Neurol on June 01, 1975

Authors

L B Rorke, D H Gilden, Z Wroblewska, D Santoli

Articles by these authors

Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci U S A (1979) 4.98

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med (1978) 4.86

The varicella zoster virus vasculopathies: clinical, CSF, imaging, and virologic features. Neurology (2008) 4.78

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res (1999) 4.26

Nonaccidental head injury in infants--the "shaken-baby syndrome". N Engl J Med (1998) 3.46

Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. J Immunol (1992) 3.15

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol (1999) 3.08

Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry (2001) 3.00

The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology (2007) 2.76

Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci U S A (1996) 2.71

Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol (2000) 2.70

Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68

MR of spinal cord ganglioglioma. AJNR Am J Neuroradiol (1998) 2.63

Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings. N Engl J Med (1978) 2.55

Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol (1987) 2.54

Herpes simplex type 1 DNA in human brain tissue. Proc Natl Acad Sci U S A (1981) 2.45

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J Exp Med (1978) 2.43

Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol (1996) 2.41

Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37

Varicella-zoster virus DNA in human sensory ganglia. Nature (1984) 2.34

Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest (1992) 2.30

The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol (1983) 2.22

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg (1998) 2.22

Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med (2001) 2.18

Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A (1983) 2.12

Cell-mediated cytotoxicity against virus-infected target cells in humans. II. Interferon induction and activation of natural killer cells. J Immunol (1978) 1.99

Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery (1993) 1.92

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol (1999) 1.89

Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev (1979) 1.88

Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol (1992) 1.88

Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J Virol (1994) 1.85

Intramedullary spinal cord tumors in children under the age of 3 years. J Neurosurg (1996) 1.84

Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology (2000) 1.84

Search for varicella zoster virus in giant cell arteritis. Ann Neurol (1998) 1.78

Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood (1987) 1.77

Ventriculus terminalis of the conus medullaris: MR findings in children. AJNR Am J Neuroradiol (1995) 1.77

Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med (1993) 1.76

Spontaneous cell-mediated cytotoxicity in humans: role of interferon and immunoglobulins. J Immunol (1978) 1.71

Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg (2000) 1.71

Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66

Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia. J Virol (1995) 1.66

The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol (2001) 1.65

Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia. Ann Neurol (1992) 1.65

Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology (1984) 1.64

Medulloblastoma: clinical and biologic aspects. Neuro Oncol (1999) 1.61

Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol (1998) 1.59

New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59

Cell-mediated cytotoxicity against virus-infected target cells in humans. I. Characterization of the effector lymphocyte. J Immunol (1978) 1.58

Extraction of cell-associated varicella-zoster virus DNA with triton X-100-NaCl. J Virol Methods (1982) 1.58

Nonproductive infection of guinea pig cells with human cytomegalovirus. J Virol (1973) 1.56

HLA-related control of spontaneous and antibody-dependent cell-mediated cytotoxic activity in humans. J Immunol (1976) 1.54

Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys (1990) 1.53

Restricted transcription of varicella-zoster virus in latently infected human trigeminal and thoracic ganglia. J Infect Dis (1992) 1.52

Congenital brain anomalies associated with the hypoplastic left heart syndrome. Pediatrics (1990) 1.52

Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci U S A (1991) 1.51

Tumour cell lines induce interferon in human lymphocytes. Nature (1977) 1.50

Central nervous system anomalies associated with meningomyelocele, hydrocephalus, and the Arnold-Chiari malformation: reappraisal of theories regarding the pathogenesis of posterior neural tube closure defects. Neurosurgery (1986) 1.48

MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res (2001) 1.46

Varicella-zoster virus infection of human mononuclear cells. Virus Res (1987) 1.46

Chromosome abnormalities in pediatric brain tumors. Cancer Res (1988) 1.42

VZV spinal cord infarction identified by diffusion-weighted MRI (DWI). Neurology (2007) 1.41

Fetal akinesia deformation sequence (Pena-Shokeir phenotype) associated with acquired intrauterine brain damage. Neurology (1991) 1.41

Neuropathology of Joubert syndrome. J Child Neurol (1999) 1.41

Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial. Cancer (1993) 1.40

Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. Neurosurgery (1996) 1.40

Risk factors for astrocytic glioma and primitive neuroectodermal tumor of the brain in young children: a report from the Children's Cancer Group. Cancer Epidemiol Biomarkers Prev (1994) 1.38

Use of a lethally irradiated major histocompatibility complex nonrestricted cytotoxic T-cell line for effective purging of marrows containing lysis-sensitive or -resistant leukemic targets. Blood (1996) 1.38

Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J Virol (1984) 1.38

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors. J Clin Oncol (2000) 1.38

The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol (1995) 1.36

On finding striated muscle in the brain. J Neurol Neurosurg Psychiatry (1971) 1.33

Isolation of Herpes simplex virus from human trigeminal ganglia, including ganglia from one patient with multiple sclerosis. Lancet (1977) 1.30

Primary amebic encephalitis, probably from Acanthamoeba. Ann Intern Med (1973) 1.30

Subacute sclerosing panencephalitis: isolation of a virus encephalitogenic for ferrets. J Infect Dis (1970) 1.30

Cloning the antibody response in humans with inflammatory CNS disease: isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain. J Neuroimmunol (1999) 1.28

Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J Virol (1999) 1.25

Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation. J Neurovirol (1996) 1.25

Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer (1985) 1.25

Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines. Blood (1992) 1.25

Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatr Neurosurg (1996) 1.25

Bilateral retinoblastoma with ectopic intracranial retinoblastoma: trilateral retinoblastoma. Cancer Genet Cytogenet (1982) 1.24

Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age. J Neuropathol Exp Neurol (1973) 1.21

Imbalances in T cell subpopulations in multiple sclerosis patients. J Immunol (1978) 1.21

Survival and prognostic factors following radiation and/or chemotherapy for primitive neuroectodermal tumors of the pineal region in infants and children: a report of the Childrens Cancer Group. J Clin Oncol (1995) 1.20

Transmission of an encephalitogenic agent from brains of patients with subacute sclerosing panencephalitis to ferrets. Preliminary report. N Engl J Med (1968) 1.20

Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology (1995) 1.20

Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis. Proc Natl Acad Sci U S A (2001) 1.19

Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg (1995) 1.19

Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol (1994) 1.19

Cerebral gangliogliomas during childhood. Neurosurgery (1983) 1.19

Zoster myelitis: improvement with antiviral therapy in two cases. Neurology (1996) 1.19

Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol (1995) 1.18

Virus-specific intracytoplasmic inclusions in mouse brain produced by a newly isolated strain of Theiler virus. I. Virologic and morphologic studies. Lab Invest (1977) 1.18

Monosomy 22 in rhabdoid or atypical tumors of the brain. J Neurosurg (1990) 1.18